Literature DB >> 15602004

The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand.

Thomas P Burris1, Chahrzad Montrose, Keith A Houck, Harold E Osborne, Wayne P Bocchinfuso, Benjamin C Yaden, Christine C Cheng, Richard W Zink, Robert J Barr, Christoper D Hepler, Venkatesh Krishnan, Heather A Bullock, Lorri L Burris, Rachelle J Galvin, Kelli Bramlett, Keith R Stayrook.   

Abstract

Guggulsterone (GS) is the active substance in guggulipid, an extract of the guggul tree, Commiphora mukul, used to treat a variety of disorders in humans, including dyslipidemia, obesity, and inflammation. The activity of GS has been suggested to be mediated by antagonism of the receptor for bile acids, the farnesoid X receptor (FXR). Here, we demonstrate that both stereoisomers of the plant sterol, (E)- and (Z)-GS, bind to the steroid receptors at a much higher affinity than to FXR. Both stereoisomers bind to the mineralocorticoid receptor (MR) with a Ki value of approximately 35 nM, which is greater than 100 times more potent than their affinity for FXR. Both (E)- and (Z)-GS also displayed high affinity for other steroid receptors, including the androgen (AR), glucocorticoid (GR), and progesterone receptors (PR) with Ki values ranging from 224 to 315 nM. In cell-based functional cotransfection assays, GSs behaved as antagonists of AR, GR, and MR, but as agonists of PR. Agonist activity was also demonstrated with estrogen receptor (ER) alpha; however, the potency was very low (EC50 > 5000 nM). In addition, GS displayed activity in functional assays in cell lines expressing endogenous AR, GR, ER, and PR. These data suggest that the variety of pharmacological effects exhibited by GS may be mediated by targeting several steroid receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15602004     DOI: 10.1124/mol.104.007054

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  33 in total

1.  The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus.

Authors:  Matthew Dean; Julia Austin; Ren Jinhong; Michael E Johnson; Daniel D Lantvit; Joanna E Burdette
Journal:  Horm Cancer       Date:  2018-05-07       Impact factor: 3.869

Review 2.  Pregnane X receptor and natural products: beyond drug-drug interactions.

Authors:  Jeff L Staudinger; Xunshan Ding; Kristin Lichti
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

3.  Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.

Authors:  Shailendra Kumar Dhar Dwivedi; Nidhi Singh; Rashmi Kumari; Jay Sharan Mishra; Sarita Tripathi; Priyam Banerjee; Priyanka Shah; Vandana Kukshal; Abdul Malik Tyagi; Anil Nilkanth Gaikwad; Rajnish Kumar Chaturvedi; Durga Prasad Mishra; Arun Kumar Trivedi; Somali Sanyal; Naibedya Chattopadhyay; Ravishankar Ramachandran; Mohammad Imran Siddiqi; Arun Bandyopadhyay; Ashish Arora; Thomas Lundåsen; Sayee Priyadarshini Anakk; David D Moore; Sabyasachi Sanyal
Journal:  Mol Endocrinol       Date:  2011-04-14

4.  Conformational dynamics of human FXR-LBD ligand interactions studied by hydrogen/deuterium exchange mass spectrometry: insights into the antagonism of the hypolipidemic agent Z-guggulsterone.

Authors:  Liping Yang; David Broderick; Yuan Jiang; Victor Hsu; Claudia S Maier
Journal:  Biochim Biophys Acta       Date:  2014-06-18

5.  Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.

Authors:  Jung-Ho Lee; Matthew Dean; Julia R Austin; Joanna E Burdette; Brian T Murphy
Journal:  J Nat Prod       Date:  2018-09-10       Impact factor: 4.050

6.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

7.  Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors.

Authors:  Nidhi Singh; Manisha Yadav; Abhishek Kumar Singh; Harish Kumar; Shailendra Kumar Dhar Dwivedi; Jay Sharan Mishra; Anagha Gurjar; Amit Manhas; Sharat Chandra; Prem Narayan Yadav; Kumaravelu Jagavelu; Mohammad Imran Siddiqi; Arun Kumar Trivedi; Naibedya Chattopadhyay; Sabyasachi Sanyal
Journal:  Mol Endocrinol       Date:  2014-03-05

8.  Conformational modulation of the farnesoid X receptor by prenylflavonoids: Insights from hydrogen deuterium exchange mass spectrometry (HDX-MS), fluorescence titration and molecular docking studies.

Authors:  Liping Yang; David Broderick; Yan Campbell; Adrian F Gombart; Jan F Stevens; Yuan Jiang; Victor L Hsu; William H Bisson; Claudia S Maier
Journal:  Biochim Biophys Acta       Date:  2016-09-03

9.  Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Authors:  Rebecca J Leeman-Neill; Sarah E Wheeler; Shivendra V Singh; Sufi M Thomas; Raja R Seethala; Daniel B Neill; Mary C Panahandeh; Eun-Ryeong Hahm; Sonali C Joyce; Malabika Sen; Quan Cai; Maria L Freilino; Changyou Li; Daniel E Johnson; Jennifer R Grandis
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

10.  Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta.

Authors:  Srilatha Raghuram; Keith R Stayrook; Pengxiang Huang; Pamela M Rogers; Amanda K Nosie; Don B McClure; Lorri L Burris; Sepideh Khorasanizadeh; Thomas P Burris; Fraydoon Rastinejad
Journal:  Nat Struct Mol Biol       Date:  2007-11-25       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.